Asia-Pacific Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • May 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 67
  • No of Figures: 22

Asia-Pacific Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market, By Product (On-Premise Solutions, Cloud-Based Solutions, Web Based Solutions), Approach (Clinician Reported Outcome Assessment (ClinRO), Patient Reported Outcome Assessment (PRO), Observer Reported Outcome Assessment (ObsRO), Performance Outcome Assessment (PerfO)), End User (Commercial Service Providers, Hospitals and Transplant Centers, Research Laboratories, Academic Institutions), Platform (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Hospitals and Clinical Laboratories, Consulting Service Companies, Research and Academia, Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and Rest of Asia-Pacific) Industry Trends and Forecast to 2028

Asia-Pacific Electronic Clinical Outcome Assessment (eCOA) for Content Licensed MarketMarket Analysis and Insights: Asia-Pacific Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market

The electronic clinical outcome assessment (eCOA) for content licensed market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the highest CAGR of 15.2% in the forecast period of 2021 to 2028 and expected to reach USD 198,751.79 thousands by 2028. The rise of electronic clinical outcome assessments (eCOAs) in the age of patient centricity which is accelerating the electronic clinical outcome assessment (eCOA) for content licensed market.

Electronic clinical outcome assessment (eCOA) is the method of capturing data electronically in clinical trials. It can substantially increase the quality of study data while meeting regulatory requirements. eCOA employs technologies such as handheld devices, tablets or the web to allow trial participants, physicians and caregivers to directly report information related to healthcare outcomes.

Growing demand for eCOA due to its capability to collect large amount of data while simultaneously ensuring high quality is accelerating the electronic clinical outcome assessment (eCOA) for content licensed market. High initial financial costs associated with the implementation and utilization of these systems might restrain the electronic clinical outcome assessment (eCOA) for content licensed market. Rising levels of innovations and technological advancements (AI, ML, precision trials, precision-guided intervention, IoMT) is creating opportunities for the electronic clinical outcome assessment (eCOA) for content licensed market. Lack of well-trained professionals for accurate data interpretation is a major challenge for the electronic clinical outcome assessment (eCOA) for content licensed market.

This electronic clinical outcome assessment (eCOA) for content licensed market  report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographical expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Electronic Clinical Outcome Assessment (eCOA) for Content Licensed MarketElectronic Clinical Outcome Assessment (eCOA) for Content Licensed Market Scope and Market Size

The electronic clinical outcome assessment (eCOA) for content licensed market is segmented on the basis of product, approach, end user and platform. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the electronic clinical outcome assessment (eCOA) for content licensed market is segmented into on-premise solutions, cloud-based solutions and web based solutions. In 2021, on-premise segment holds the largest market share in electronic clinical outcome assessment (eCOA) for content licensed market as on-premise is the perpetual license with a fixed set of studies available for clients.
  • On the basis of approach, the electronic clinical outcome assessment (eCOA) for content licensed market is segmented into clinician reported outcome assessment (ClinRO), patient reported outcome assessment (PRO), observer reported outcome assessment (ObsRO) and performance outcome assessment (PerfO). In 2021, clinician reported outcome assessment (ClinRO) segment holds the largest market share in electronic clinical outcome assessment (eCOA) for content licensed market as ClinRO measure involves a clinical judgment or interpretation of the observable signs, behaviours or other physical manifestations thought to be related to a disease or condition.
  • On the basis of end user, the electronic clinical outcome assessment (eCOA) for content licensed market is segmented into commercial service providers, hospitals and transplant centers and research laboratories and academic institutions. In 2021, research laboratories and academic institutions segment holds the largest market share in electronic clinical outcome assessment (eCOA) for content licensed market as research organization and academic institution used broadly within the clinical and drug development industries, primarily refers to an academic and/or non-profit institution that performs one or more functions in the conduct of clinical trials.
  • On the basis of platform, the electronic clinical outcome assessment (eCOA) for content licensed market is segmented into contract research organization, pharmaceutical and biopharmaceutical companies, medical device manufacturers, consulting service companies, hospitals and clinical laboratories, research and academia and others. In 2021, contract research organization segment holds the largest market share in electronic clinical outcome assessment (eCOA) for content licensed market as a contract research organization (CROs) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services (for both drugs and medical devices).

Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market Country Level Analysis

Electronic clinical outcome assessment (eCOA) for content licensed market is analysed and market size information is provided by the country, product, approach, end user and platform.

The countries covered in electronic clinical outcome assessment (eCOA) for content licensed market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific.

In Asia-Pacific region, China is dominating due to rise of electronic clinical outcome assessments (eCOAs) in the age of patient centricity.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Number of Clinical Trials

The electronic clinical outcome assessment (eCOA) for content licensed market also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in electronic clinical outcome assessment (eCOA) for content licensed and changes in regulatory scenarios with their support for the electronic clinical outcome assessment (eCOA) for content licensed market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market Share Analysis

The electronic clinical outcome assessment (eCOA) for content licensed market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Asia-Pacific electronic clinical outcome assessment (eCOA) for content licensed market.

The major players covered in the report are Oracle, IBM Corporation, Dassault Systemes, Parexel International Corporation, ERT Clinical, eClinical Solutions LLC, ArisGlobal, Kayentis, Anju Software, Inc., Signant Health, WIRB-Copernicus Group and Bioclinica among others local and Asia-Pacific players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the growth of electronic clinical outcome assessment (eCOA) for content licensed market.

For instance,

  • In February 2021, ERT Clinical, a leading global data and technology company for clinical endpoint data collection has introduced a powerful new solution eCOA Multimedia for enabling the collection, processing and analysis of photos and audio as part of clinical trial eCOA assessments. With this new launch, the company has increased its product line. 

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for electronic clinical outcome assessment (eCOA) for content licensed through expanded range of size.

Customization Available: Asia-Pacific Electronic Clinical Outcome Assessment (eCOA) for Content Licensed Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 2 ASIA-PACIFIC ON-PREMISE SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 3 ASIA-PACIFIC CLOUD BASED SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 4 ASIA-PACIFIC WEB BASED SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 5 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 6 ASIA-PACIFIC CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 7 ASIA-PACIFIC PATIENT REPORTED OUTCOME ASSESSMENT (PRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 8 ASIA-PACIFIC OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 9 ASIA-PACIFIC PERFORMANCE OUTCOME ASSESSMENT (PERFO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 10 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 11 ASIA-PACIFIC RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 12 ASIA-PACIFIC HOSPITALS AND TRANSPLANT CENTERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 13 ASIA-PACIFIC COMMERCIAL SERVICE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 14 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 15 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 16 ASIA-PACIFIC PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 17 ASIA-PACIFIC MEDICAL DEVICE MANUFACTURERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 18 ASIA-PACIFIC HOSPITALS AND CLINICAL LABORATORIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 19 ASIA-PACIFIC CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 20 ASIA-PACIFIC RESEARCH AND ACADEMIA IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 21 ASIA-PACIFIC OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)

TABLE 22 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)

TABLE 23 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 24 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 25 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 26 ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 27 CHINA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 28 CHINA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 29 CHINA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 30 CHINA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 31 JAPAN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 32 JAPAN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 33 JAPAN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 34 JAPAN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 35 AUSTRALIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 36 AUSTRALIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 37 AUSTRALIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 38 AUSTRALIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 39 SOUTH KOREA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 40 SOUTH KOREA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 41 SOUTH KOREA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 42 SOUTH KOREA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 43 INDIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 44 INDIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 45 INDIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 46 INDIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 47 SINGAPORE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 48 SINGAPORE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 49 SINGAPORE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 50 SINGAPORE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 51 THAILAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 52 THAILAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 53 THAILAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 54 THAILAND ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 55 MALAYSIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 56 MALAYSIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 57 MALAYSIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 58 MALAYSIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 59 INDONESIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 60 INDONESIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 61 INDONESIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 62 INDONESIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 63 PHILIPPINES ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

TABLE 64 PHILIPPINES ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)

TABLE 65 PHILIPPINES ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)

TABLE 66 PHILIPPINES ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)

TABLE 67 REST OF ASIA-PACIFIC ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions